Fibrocystic breast changes: Clinical sciences

1,073views

Fibrocystic breast changes: Clinical sciences

OB/Gyn

OB/Gyn

Antepartum fetal surveillance: Clinical sciences
Induction of labor: Clinical sciences
Approach to first trimester bleeding: Clinical sciences
Group B streptococcus (GBS) colonization in pregnancy: Clinical sciences
Herpes simplex virus infection in pregnancy: Clinical sciences
Urinary tract infections and kidney stones in pregnancy: Clinical sciences
Intraamniotic infection: Clinical sciences
Approach to postpartum hemorrhage: Clinical sciences
Placenta accreta spectrum: Clinical sciences
Uterine atony: Clinical sciences
Approach to postpartum fever: Clinical sciences
Late-term and postterm pregnancy: Clinical sciences
Emergency contraception: Clinical sciences
Permanent contraception (sterilization): Clinical sciences
Reversible contraception: Clinical sciences
Therapeutic and induced abortions: Clinical sciences
Approach to vulvar skin disorders: Clinical sciences
Approach to dysuria: Clinical sciences
Approach to urinary incontinence (GYN): Clinical sciences
Approach to chronic pelvic pain (GYN): Clinical sciences
Endometriosis: Clinical sciences
Approach to acute pelvic pain (GYN): Clinical sciences
Approach to a breast mass and asymmetry: Clinical sciences
Breast papilloma: Clinical sciences
Fibroadenoma: Clinical sciences
Inflammatory breast cancer: Clinical sciences
Invasive lobular carcinoma: Clinical sciences
Ductal carcinoma in situ: Clinical sciences
Fibrocystic breast changes: Clinical sciences
Invasive ductal carcinoma: Clinical sciences
Lobular carcinoma in situ: Clinical sciences
Approach to primary amenorrhea: Clinical sciences
Approach to secondary amenorrhea: Clinical sciences
Polycystic ovary syndrome (PCOS): Clinical sciences
Approach to postmenopausal bleeding: Clinical sciences
Approach to dysmenorrhea: Clinical sciences
Gestational trophoblastic disease (GTD) and neoplasia (GTN): Clinical sciences
Infertility: Clinical sciences
Uterine leiomyoma: Clinical sciences

Decision-Making Tree

Transcript

Watch video only

Fibrocystic breast changes include a spectrum of benign breast changes characterized by multiple bilateral nodules within the breast tissue. This condition is most commonly found in females between the ages of 30 and 50 years. Although the exact etiology is not fully understood, a hormonal component, such as overproduction of estrogen and underproduction of progesterone is likely, especially since symptoms like breast pain, also known as mastalgia, tend to worsen in a cyclical pattern towards the end of the menstrual cycle.

Alright, now, when a patient presents with a chief concern suggesting fibrocystic breast changes, the first step is to obtain a focused history and perform a physical examination. The patient might report bilateral breast nodularity, pain, swelling, and possible straw-colored nipple discharge. These symptoms may worsen just prior to menstruation each month. On physical examination, you might find multiple nodular areas, a ropey and lumpy texture, and tenderness on palpation. At this point, you should suspect fibrocystic breast changes.

The next step is to order a breast imaging to confirm your diagnosis. Now, if your patient is younger than 35 years, order a breast ultrasound; but, if your patient is 35 years of age or older, you should obtain both a breast ultrasound and a mammogram.

Okay, let’s talk about the results. If there are no findings on imaging that would indicate fibrocystic breast changes, then you should consider an alternative diagnosis. On the other hand, ultrasound findings consistent with fibrocystic breast changes include fibroglandular tissue, clustered microcysts, distorted breast parenchyma, and an absence of discrete masses. As for the mammogram, it might show heterogeneous and dense breast parenchyma, partially circumscribed cysts, as well as crescent-shaped calcifications in multiple lobes. If you see these findings on imaging, then you are dealing with fibrocystic breast changes.

Alright, now that we diagnosed fibrocystic breast changes, let’s move on to management. Keep in mind that fibrocystic breast changes per se don't need to be treated; what’s actually treated are the symptoms of the disorder, such as mastalgia.

Sources

  1. "Practice Bulletin No. 164: Diagnosis and management of benign breast disorders" Obstet Gynecol (2016)
  2. "Select Choices in Benign Breast Disease: An Initiative of the American Society of Breast Surgeons for the American Board of Internal Medicine Choosing Wisely® Campaign" Ann Surg Oncol (2018)
  3. "Diseases of the Breast" The Mont Reid Surgical Handbook, 7th ed (2018)
  4. "Clustered Microcysts at Breast US: Outcomes and Updates for Appropriate Management Recommendations" Radiology (2020)
  5. "Benign breast diseases: classification, diagnosis, and management" Oncologist (2006)
  6. "Benign breast disorders" N Engl J Med (2005)
  7. "Benign breast disease: when to treat, when to reassure, when to refer" Cleve Clin J Med (2002)